Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technetium-99m antimony colloid for bone-marrow imaging

A A Martindale, J M Papadimitriou, J H Turner

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |November 1, 1980
    PubMed
    Summary

    Technetium-99m antimony colloid, a novel agent for bone-marrow imaging, shows superior uptake and imaging in rabbits compared to technetium-99m sulfur colloid. This new colloid targets specific bone marrow phagocytes for enhanced visualization.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endoplasmic reticulum mediates mitochondrial transfer within the osteocyte dendritic network.

    Science advances·2019
    Same author

    Erratum: Author Correction: Exosomes-the enigmatic regulators of bone homeostasis.

    Bone research·2019
    Same author

    Exosomes-the enigmatic regulators of bone homeostasis.

    Bone research·2018
    Same author

    Selecting for productivity within a strain of cotton, Gossypium hirsutum L., in three environments.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2014
    Same author

    Performance of cotton (Gossypium hirsutum L.) lines selected for high productivity in three environments.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2014
    Same author

    AIDS in Africa: distinguishing fact and fiction.

    World journal of microbiology & biotechnology·2014

    Area of Science:

    • Nuclear Medicine
    • Radiopharmacology
    • Biomedical Imaging

    Background:

    • Bone marrow imaging is crucial for diagnosing various hematological and oncological conditions.
    • Current imaging agents like technetium-99m sulfur colloid have limitations in particle size and targeting specificity.
    • Development of novel radiocolloids is essential for improving diagnostic accuracy in bone marrow imaging.

    Purpose of the Study:

    • To prepare and characterize technetium-99m antimony colloid for bone marrow imaging.
    • To evaluate the biodistribution and imaging characteristics of technetium-99m antimony colloid in animal models.
    • To compare the efficacy of technetium-99m antimony colloid with technetium-99m sulfur colloid for bone marrow imaging.

    Main Methods:

    • Technetium-99m antimony colloid was synthesized using polyvinylpyrrolidone for particle size control (1-13 nm).

    Related Experiment Videos

  • Particle size was determined using electron microscopy.
  • Biodistribution and imaging studies were conducted in rabbits and rats, comparing uptake with technetium-99m sulfur colloid.

    • Main Results:

    • Optimal technetium-99m antimony colloid particles (1-13 nm) were produced.
    • In rabbits, the colloid concentrated exclusively in subendothelial dendritic phagocytes within bone marrow sinusoids.
    • Bone marrow imaging in rabbits demonstrated superior performance of technetium-99m antimony colloid over technetium-99m sulfur colloid; rats showed higher bone marrow uptake but slower blood clearance for antimony colloid.

    Conclusions:

    • Technetium-99m antimony colloid is a promising radiopharmaceutical for bone marrow imaging due to its specific targeting and improved imaging characteristics.
    • The smaller particle size and specific cellular uptake mechanism contribute to its enhanced efficacy compared to technetium-99m sulfur colloid.
    • Further investigation is warranted to optimize blood clearance and clinical application of technetium-99m antimony colloid.